Biblio

Author Title [ Type

] Year

Filters: Author is Kim, Jin Seok [Clear All Filters]

Journal Article

Kim YRi, Shin HJin, Yhim H-Y, Yang D-H, Park Y, Lee JHyun, Lee W-S, Do YRok, Mun Y-C, Kim DSik, et al. Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in diffuse large B-cell lymphoma: a multicenter retrospective study. Front Oncol. 2024;14:1363385.

Röth A, Ichikawa S, Ito Y, Kim JSeok, Nagy Z, Obara N, Panse J, Schrezenmeier H, Sica S, Soret J, et al. Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial. Eur J Haematol. 2023.

Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.

Jang JEun, Hwang DYu, Chung H, Kim S-J, Eom J-I, Jeung H-K, Song J, Kim JSeok, Cheong J-W, Min YHong. Early cytomegalovirus reactivation and expansion of CD56CD16DNAM1 natural killer cells are associated with anti-leukemia effect after haploidentical stem cell transplantation in acute leukemia. Biol Blood Marrow Transplant. 2019.

Kim YRi, Kim SHoon, Chang JHee, Suh C-O, Kim S-J, Kim Y, Hwang DYu, Jang JEun, Hyun SYoung, Cheong J-W, et al. Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response. Ann Hematol. 2013.

Kook HWon, Jang JEun, Min C-K, Yoon DHyun, Kim K, Bang S-M, Park Y, Lee JHoon, Yoon S-S, Kim JSeok. A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea. J Korean Med Sci. 2024;39(2):e5.

Shin H-J, Kim D-Y, Kim K, Min C-K, Lee J-J, Mun Y-C, Lee W-S, Lim S-N, Kim JSeok, Moo JHo, et al. Nation-Wide Retrospective Analysis of Allogeneic Stem Cell Transplantation in Patients with Multiple Myeloma: A Study from Korean Multiple Myeloma Working Party (KMM1913). Cancer Res Treat. 2024.

Yi JHo, Jeong SHyun, Kim SJin, Yoon DHyun, Kang HJin, Koh Y, Kim JSeok, Lee W-S, Yang D-H, Do YRok, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.